ライフサイエンスコーパス: Env protein

1 l proteins and a singly spliced mRNA encodes Env protein.

2 ous neutralization determinants on the HIV-1 Env protein.

3 d on the surface of the gp120 subunit of the Env protein.

4 icular stomatitis virus (VSV) expressing HIV Env protein.

5 ch region in the surface (SU) subunit of the Env protein.

6 binant expressing a secreted form of the HIV Env protein.

7 levels of antibody responses against the HIV Env protein.

8 boosted (week 8) with the DNA or recombinant Env protein.

9 he induction of XC cell syncytia by the R(+) Env protein.

10 Env protein but not that induced by the R(-) Env protein.

11 ell-specific syncytium formation by the R(+) Env protein.

12 mic domain of gp41 and the ectodomain of the Env protein.

13 ntical or chemically conserved in the HTLV-1 Env protein.

14 diversity and poor immunogenicity of the HIV Env protein.

15 rize the phenotypic features of the M-tropic Env protein.

16 ts a need for broad antibodies targeting the Env protein.

17 with about 500 glycoforms characterized per Env protein.

18 ved Gag and the cytoplasmic tail (CT) of the Env protein.

19 usion-inducing conformational changes in the Env protein.

20 ents of HTLV-3 using independently expressed Env proteins.

21 uld confer this property on two heterologous Env proteins.

22 tness similar to those carrying the mothers' Env proteins.

23 h MA facilitates the virion incorporation of Env proteins.

24 tance mutations into phenotypically distinct Env proteins.

25 e leukemia virus (MLV), bearing heterologous Env proteins.

26 rotocol with their homologous vaccine native Env proteins.

27 endent virus, and with subgroups A or B ASLV Env proteins.

28 ls that were transformed by the JSRV or ENTV Env proteins.

29 ke particles (VLPs), both FV and HBV require Env proteins.

30 cted an enhanced fusogenicity of the mutated Env proteins.

31 proliferative responses to both SIV gag and env proteins.

32 ning technique of obtaining novel retargeted Env proteins.

33 properties have been described for subtype C Env proteins.

34 ) that are buried in the parental, unadapted Env proteins.

35 r the 17b antibody than are IFITM3-resistant Env proteins.

36 rains LAI and NL4.3 lack wild-type levels of Env proteins.

37 HERV-K(HML-2)] and the expression of Gag and Env proteins.

38 ons in the HR1 region of the viral envelope (Env) protein.

39 e V3 glycan supersite on the HIV-1 envelope (Env) protein.

40 he sequence of the capsid (CA) and envelope (Env) proteins.

41 the amphotropic murine leukemia virus 4070A Env protein (2).

42 -displayed human antibody library; these two Env proteins (89.6 and IIIB gp140s), and one additional

43 ccine will include a recombinant form of the Env protein, a trimer located on the virion surface.

44 Here, we investigated whether ENV protein affects oligodendroglial differentiation.

45 bsets prior to immunization with recombinant Env protein affects the vaccine-induced Ab response in m

46 of the IgG binding response than those with Env protein alone.

47 The viral envelope (Env) protein alone can transform cultured cells, and we

48 e show that expression of the JSRV envelope (Env) protein alone in lungs of mice, by using a replicat

49 anding of the humoral responses to the HIV-1 Env protein and provide insights regarding the most rele

50 (MD) simulations of a model glycosylated HIV Env protein and related systems.

51 by proteolytic cleavage of Gag, Gag-Pol, and Env proteins and by their morphology.

52 ximately normal amounts of Gag, Gag-Pol, and Env proteins and genomic viral RNA (vRNA), but several m

53 ortant influences on the quality of trimeric Env proteins and hence their suitability as vaccine comp

54 tivated in cells transformed by JSRV or ENTV Env proteins and in cells transformed by the proteins wi

55 reflect different interactions between their Env proteins and molecules on CD4(+) and CD8(+) T cells

56 V Env proteins or an interaction between the Env proteins and PI3K in the transformed cells.

57 human immunodeficiency virus type 1 (HIV-1) Env proteins and possess broad neutralizing activities.

58 enome, in addition to the structural Gag and Env proteins and retroviral enzymes, carries a region at

59 l conformational heterogeneity of some HIV-1 Env proteins and, by extrapolation, also vaccine immunog

60 obe interactions between the viral envelope (Env) protein and CXCR4 and to identify pathways by which

61 ) in the gp41 subunit of the viral envelope (Env) protein and prevents conformational changes require

62 ns within the V3 loop of the viral envelope (Env) protein and was modulated by additional mutations i

63 ined viral sequences in their DNA, expressed Env protein, and showed retroviral particles by electron

64 ular protein, Zfp111, that binds to the JSRV Env protein, and this binding plays a role in Env transf

65 ssing the human immunodeficiency virus (HIV) Env protein are nonpathogenic in mice, even when given b

66 However, the precise mechanism by which Env proteins are acquired during virus assembly has yet

67 IFITM3-sensitive Env proteins are also more susceptible to neutralization

68 These data suggest that VIR165-dependent Env proteins are kinetically trapped in the unliganded s

69 To increase yield and simplify purification, Env proteins are often made in truncated, soluble forms.

70 ubstantial subset of potential epitopes when Env proteins are used as immunogens.

71 and ecotropic murine leukemia virus (E-MLV) Env proteins as donor virions.

72 The HIV-1 Env proteins assemble as trimers, and incorporation of t

73 f trimer spokes have been observed to impair Env protein assembly into virus particles, and several o

74 to HIV-1 gp120, suppress interactions of the Env protein at host cell receptor binding sites, inhibit

75 recombinant expressing the membrane-anchored Env protein at producing CD8 T cells and antibody respon

76 nstrated to contain high levels of the viral env proteins, averaged 70-79 trimers per virion in tomog

77 Chimeric Env proteins between JSRV and the unrelated murine retro

78 ncept that a distally related retroviral SIV Env protein boost can increase pre-existing NAb response

79 v and monovalent gag) followed by a 5-valent Env protein boost for seronegative adults was previously

80 These data demonstrate that the adjuvanted Env protein boost is critical for protecting against hig

81 through a DNA prime, recombinant oligomeric Env protein boost regimen.

82 vs) DNA prime, followed by a SIVmac239 gp140 Env protein boost that aimed to focus the immune respons

83 prime-recombinant NYVAC (rNYVAC) vector and Env protein boost vaccination strategy.

84 of the alphavirus replicon vector prime plus Env protein boost vaccine approach for the induction of

85 Here we show that Ad prime, Env protein boost vaccines protect against neutralizatio

86 at received the intramuscular VRP prime plus Env protein boost were completely protected.

87 Recombinant Gag and Env protein boosting elicited rapid and strong recall re

88 Of note, Env protein boosting induced serum-neutralizing antibodi

89 rated that were predominantly detected after Env protein boosting.

90 e characteristics and immunogenicity of this Env protein, both alone and mixed together with a clade

91 ediate entry of virions bearing JSRV or ENTV Env proteins, bound JSRV SU poorly if at all, and did no

92 tion of XC cell syncytia induced by the R(+) Env protein but not that induced by the R(-) Env protein

93 that the FIV tetherin antagonist is also its Env protein, but the mechanism is distinctive.

94 g antibodies (nAbs) to some cloned SIVsmE660 Env proteins, but antibodies able to neutralize the chal

95 e to restore BST-2 antagonism to an inactive Env protein by a single-amino-acid change.

96 man immunoglobulin G that reacted with HIV-1 Env proteins by enzyme-linked immunosorbent assay and ne

97 ild-type and palmitoylation-deficient mutant Env proteins by using extraction with the mild detergent

98 Here we show that JSRV and ENTV Env proteins can also transform Madin-Darby canine kidne

99 Env proteins can better mediate entry into cells after c

100 sformation of mouse fibroblasts and that the Env proteins can transform at least some cells by a Hyal

101 These results show that the JSRV and ENTV Env proteins can transform epithelial cells besides BEAS

102 gested the hypothesis that the JSRV and ENTV Env proteins cause cancer by inhibiting the tumor suppre

103 s so they may not accurately represent HIV-1 Env proteins circulating in humans, potentially limiting

104 Thus, an HIV-1 subtype C Env protein (CO6980v0c22) from an infected person in the

105 diated at least in part by the YFV envelope (env) protein coding RNA.

106 sary for the formation of a fully functional Env protein complex.

107 r proteins may influence surface exposure of Env protein complexes in virus-infected cells, assisting

108 n overlapping peptide pools from three HIV-1 Env proteins, CON6, MN (subtype B), and Chn19 (subtype C

109 region of Env, suggesting subtle changes in Env protein conformation.

110 NLHX; however, all of the PFI-insusceptible Env proteins conserved the sequence of a critical enfuvi

111 us type 1) uses its trimeric gp160 envelope (Env) protein consisting of non-covalently associated gp1

112 Moreover, some soluble recombinant Env proteins contain aberrant disulfide bonds that are n

113 es syncytium formation with cells expressing Env protein containing R peptide (R(+) Env), which is kn

114 We studied chimeric Env proteins containing different V3 loop sequences and

115 unodeficiency virus type 1 (HIV-1) envelope (Env) protein contains numerous N-linked carbohydrates th

116 Among HIV-1 gene products, the envelope (Env) protein contains variable as well as conserved regi

117 versification, even though antibodies to the Env protein could be detected much earlier.

118 fected by ENTV vectors, even though the ENTV Env protein could bind well to human Hyal2 expressed on

119 humoral and cellular immune responses to the Env protein could reveal potential determinants of vacci

120 possibility that these endogenous retroviral Env proteins could directly influence HIV-1 replication.

121 virions by virtue of an interaction with the Env protein cytoplasmic tails (CTs).

122 For both X4-tropic and R5-tropic Env proteins, DeltaCT induced faster fusion kinetics tha

123 the CD4-binding site of the HIV-1 envelope (Env) protein (denoted VRC01) was modified by site-direct

124 irus envelope (Env) have been conducted with Env proteins derived from clade B viruses isolated durin

125 en soluble gp140 and virion-associated gp160 Env proteins derived from SF162 may be the basis for the

126 tion sensitivities of HIV-1 pseudotyped with Env proteins derived from two prototypic clade B primary

127 ay measurable binding to a recombinant gp140 Env protein (derived from the dual-tropic 89.6 virus), w

128 protein in the boosting phase along with the Env protein did not contribute further to the preservati

129 The results demonstrated that ancestral Env proteins did not impart broad levels of protection a

130 S mutation into heterologous R5, X4, or R5X4 Env proteins did not impart CD4 independence, it did aff

131 rsions of CZA97.012 and 92UG037.8 oligomeric Env proteins do not resemble the trimeric Env glycoprote

132 These findings suggest that the Env protein domains responsible for spongiogenesis repre

133 candidate HIV-1 vaccine vectors and purified Env proteins elicited potent and durable humoral immune

134 Seven new epitopes mapped to the viral Env protein, emphasizing Env as a major target of CTLs.

135 possessed long env open reading frames, the Env proteins encoded by these loci were nonfunctional ac

136 e localized the transforming activity to the Env proteins encoded by these viruses, which require the

137 ntry, and entry is mediated by the envelope (Env) proteins encoded by these viruses.

138 However, mosaic Env proteins expressed as trimers have not been previous

139 We found HERV-K env protein expression in 88% of BC (n = 119) but not in

140 ine leukemia virus retroviral Envelope (FeLV Env) protein for productive infection of feline AH927 ce

141 The Env protein from gibbon ape leukemia virus (GaLV) has be

142 ne (expressing clade B Gag, Pol, and Nef and Env proteins from clades A, B, and C) was administered a

143 he context of seven different parental HIV-1 Env proteins from diverse subtypes.

144 nsmitting HIV-1C-infected women against four Env proteins from heterologous viruses.

145 ggest that a multicomponent vaccine encoding Env proteins from multiple clades of HIV-1 can generate

146 large numbers of SHIV constructs expressing Env proteins from newly transmitted HIV-1 strains.

147 The entry tropism of HIV-1 Env proteins from virus isolated from the blood and geni

148 We have analyzed HIV-1 envelope (Env) proteins from 66 individuals infected with the majo

149 n for their ability to incorporate envelope (Env) proteins from other retroviral strains and genera,

150 odies, soluble HIV-1 envelope glycoproteins (Envs proteins) from two isolates complexed with two-doma

151 However, recent structural studies of HIV-1 Env proteins, generation of novel bNAbs, maturation of t

152 articles that contained higher levels of the Env protein gp120.

153 The HIV envelope (Env) protein gp120 is protected from antibody recognitio

154 ng to the HR-1 region of the viral envelope (Env) protein gp41 subunit.

155 ults indicate that the R peptide of the MuLV Env protein has a sequence-dependent inhibitory effect o

156 mmunodeficiency virus type 1 (HIV-1) surface Env protein has been implicated in the development of HI

157 roid plexus cells stably expressing the JSRV Env protein, human 293T cells, mouse NIH 3T3 cells, or N

158 10-fold more Ag-specific GC Tfh cells in HIV Env protein-immunized macaques (BG505 SOSIP).

159 Whether non-clade B Env protein immunogens will elicit antibodies with epito

160 ble of lysing target cells expressing HERV-K env protein in BC patients but not in normal female cont

161 s were primed with VRP and then boosted with Env protein in MF59 adjuvant, or they were given VRP int

162 62) gp140DeltaV2 envelope (Env) and trimeric Env protein in MF59 adjuvant.

163 n to suppress the fusogenic potential of the Env protein in other susceptible cells.

164 s Env (Con-S), and a global trivalent mosaic Env protein in rhesus macaques.

165 domain (CTD) of murine leukemia virus (MuLV) Env protein in viral fusion was indicated by the potent

166 Here, we examined the role of the Env protein in virus-induced mammary tumorigenesis in vi

167 d characterized viruses pseudotyped with the Env proteins in a single-round drug sensitivity assay.

168 the virus ensures the production of Gag and Env proteins in an appropriate ratio remains unknown.

169 Expression of the JSRV envelope (Env) protein in mouse airway epithelial cells induces si

170 between T cell-tropic and macrophage-tropic Env proteins, including functional differences with host

171 y, entry kinetics, intrinsic infectivity, or Env protein incorporation.

172 suppress transformation by the JSRV or ENTV Env proteins, indicating that mouse Hyal2 plays no role

173 activity with both the wild-type and mutant Env proteins, indicating that palmitoylation or raft ass

174 The R(+) Env protein induced syncytia in XC cells expressing a mu

175 rAd41 expressing HIV envelope (Env) protein induced cellular immune responses comparabl

176 litates the incorporation of HIV-1 envelope (Env) proteins into virions by virtue of an interaction w

177 he human immunodeficiency virus type 1 gp120 Env protein is a key domain in Env due to its role in in

178 as the R peptide, the fusion activity of the Env protein is activated.

179 These results indicate that the MuLV Env protein is associated with lipid rafts and that palm

180 Although the GALV Env protein is commonly used to make high-titer pseudoty

181 h lipid rafts and that palmitoylation of the Env protein is critical for lipid raft association.

182 We demonstrated that the ENV protein is present in close proximity to TLR4-expres

183 at the more promiscuous use of CCR5 by these Env proteins is selected against at the level of virus t

184 The gp120 subunit of the HIV-1 envelope (Env) protein is heavily glycosylated at approximately 25

185 human immunodeficiency virus (HIV) envelope (Env) protein is incorporated into HIV virions or virus-l

186 f the murine leukemia virus (MuLV) envelope (Env) protein is known to play an important role in regul

187 of these simple retroviruses, the envelope (Env) protein is the active oncogene.

188 We analyzed the properties of multiple Env proteins isolated from five patients who experienced

189 The Env proteins isolated from the genital tract of subject

190 ported on a panel of HIV-1 clade B envelope (Env) proteins isolated from a patient treated with the C

191 However, a mutant Env protein lacking this region remained associated with

192 In addition, KoRV env protein lacks an intact CETTG motif that we have ide

193 essing JSRV Env caused a marked reduction in Env protein levels, indicating that human Hyal2 suppress

194 The trimeric Moloney murine leukemia virus Env protein matures by two proteolytic cleavages.

195 These results suggest that some engineered Env proteins may more efficiently direct responses towar

196 In addition, the ENTV Env protein mediates virus entry using the same receptor

197 gths of the individual Env-receptor bonds of Env proteins obtained from a HIV-1 infected patient prio

198 rs target in some manner the highly variable Env protein of HIV-1, there are likely to be challenges

199 The Env protein of murine leukemia virus matures by two clea

200 r their ability to inhibit entry mediated by Env proteins of delta- and gammaretroviruses.

201 The Env proteins of FV and murine leukemia virus (MuLV) were

202 at Hyal2, can suppress transformation by the Env proteins of JSRV and ENTV.

203 We tested the Env proteins of JSRV and MMTV, as well as human endogeno

204 ically evaluated the differences between the Env proteins of simian immunodeficiency virus/simian HIV

205 characteristics of the binding of V3 MAbs to Env proteins of the subtype B virus JR-FL and the subtyp

206 ere we show that as with JSRV, the envelope (Env) protein of ENTV can transform cultured cells and th

207 The envelope (Env) protein of HERV-K18 encodes a superantigen that str

208 The envelope (Env) protein of HIV is the major viral determinant that

209 LaSota/gp160, expressing the gp160 envelope (Env) protein of HIV-1 from an added gene.

210 The envelope (Env) protein of human immunodeficiency virus type 2 (HIV

211 The envelope (Env) protein of Moloney murine leukemia virus (MoMuLV) i

212 DNA vaccines expressing the envelope (Env) protein of the human immunodeficiency virus have be

213 t peptide in the Vr1 region of the envelope (Env) proteins of feline leukemia virus (FeLV) subgroups

214 The engineering of soluble Env proteins on which the PG9 and PG16 epitopes are opti

215 aced by that of the wild-type or mutant MuLV Env protein or in which the cytoplasmic tail sequence of

216 y of SU for appropriate configuration of the Env protein or independent activation by SU of a signali

217 ect tyrosine phosphorylation of JSRV or ENTV Env proteins or an interaction between the Env proteins

218 gether, these studies indicate that the MMTV Env protein participates in mammary epithelial cell tran

219 erate in culture; express Tax, Rex, Gag, and Env proteins persistently; and transmit HTLV-1 to naive

220 agsiekte sheep retrovirus Env transgene, the Env protein physically associates with HYAL2.

221 method could influence the proportion of an Env protein population that contained aberrant disulfide

222 The gp145 Env protein presented in this study forms physical trime

223 eneral, the alanine mutations did not affect Env protein production or its localization to the plasma

224 fficiency and fusion competency of the viral Env proteins relate to infection during this transition

225 erior envelope glycoprotein (Env), nonnative Env protein released from cells, and the glycan shieldin

226 For HIV-2, the envelope (Env) protein replaces the role of Vpu.

227 ous data have shown that the HIV-1 Envelope (Env) protein requires an interaction with MA for assembl

228 and that at least two of the most expressed Env proteins retain their ability to make a protein.

229 e always replaced, both coding for envelope (Env) protein segments: the N terminus of the surface sub

230 unodeficiency virus type 1 (HIV-1) envelope (Env) protein serves as a barrier to antibody-mediated ne

231 accines and therapeutics targeting the HIV-1 Env protein should consider virus variation within indiv

232 Moreover, this engineered mini-Env protein should facilitate three-dimensional structur

233 ans when using the SHIV/macaque model, HIV-1 Env proteins should be identified that use mCD4 as a fun

234 ion to the V5 variable loop of the envelope (Env) protein showed that viruses bearing HI insertions r

235 ncreased breadth of recognition of different Env proteins, suggesting anti-V regions 1 and 2 Abs may

236 l of both domains is required to enhance HIV Env protein surface stability.

237 In Gag, Pol, and Env proteins, TAN1 differed from west-central African SI

238 iciency virus type 1 (HIV-1) HXBc2 envelope (Env) protein, termed 8x, mediates infection of CD4-negat

239 the marked neutralization sensitivity of all Env proteins tested to human immunodeficiency virus-posi

240 fication of a novel nuclear form of the JSRV Env protein that binds Zfp111.

241 HIV-1 B/C recombinant, native-like trimeric Env protein that is highly resistant to CD4-induced conf

242 we have identified amino acid regions in the Env proteins that are important for virus entry.

243 Here, we identified several soluble gp140 Env proteins that are recognized by PG9 and PG16, and we

244 trimer adds to the repertoire of native-like Env proteins that are suitable for immunogenicity and st

245 The identification of soluble Env proteins that express the PG9 and PG16 epitopes and

246 neutralization determinants in heterologous Env proteins that may prove useful for vaccine developme

247 bored genetically and phenotypically diverse Env proteins that used CCR5 and/or CXCR4 to elicit membr

248 ing on D17 canine cells yielded D17-specific Env proteins that used the FeLV-C receptor.

249 ansmitted to infants IP, but not IU, encoded Env proteins that were shorter and had fewer putative N-

250 We created several chimeric Env proteins that, unlike the parental Env, do not trans

251 unodeficiency virus type-1 (HIV-1) envelope (Env) proteins that mediate membrane fusion represent a m

252 perties of the viral envelope glycoproteins (Env proteins) that influence the ability of HIV-1 to ind

253 T cell responses engendered was against the Env protein, the Mamu-A*02-restricted epitope, Env(788-7

254 nclude that for both X4-tropic and R5-tropic Env proteins, the CT facilitates conformational changes

255 tions are commonly observed in ENF-resistant Env proteins, though their role remains unclear.

256 ate the cell surface expression of envelope (Env) proteins through peptide sequences located in the c

257 roglial precursor cells were stimulated with ENV protein to determine the effects of this ligand/rece

258 not significantly alter the capacity of the Env protein to mediate fusion, so they have not radicall

259 9E), giving rise to a reduced ability of the Env proteins to both induce fusion and to establish prod

260 ogeneity in the susceptibility of individual Env proteins to coreceptor inhibitors.

261 of anti-Env Abs can be improved by coupling Env proteins to costimulatory molecules such as a prolif

262 MAbs, C108g did not block binding of soluble Env proteins to either the CD4 or the CCR5 receptor, but

263 ining synthetic Galcer and recombinant HIV-1 Env proteins to identify antibodies that would block the

264 which multivalent binding of trimeric HIV-1 Env proteins to MA trimers contributes to the process of

265 t that multivalent binding of trimeric HIV-1 Env proteins to MA trimers contributes to the process of

266 We conclude that ovine betaretrovirus Env proteins transform the rodent fibroblasts by indirec

267 These Env proteins used an unidentified non-FeLV receptor for

268 The HIV envelope (Env) protein uses a dense coat of glycans to mask conser

269 eceptor responses to SHIV(AD8) infection and Env protein vaccination with eight different adjuvants.

270 This study describes a candidate HIV-1 Env protein vaccine whose sequence has been designed by

271 both alone and mixed together with a clade C Env protein vaccine, are described.

272 idual represents a source of closely related Env protein variants that can be used to explore various

273 We have used BLV Env protein variants to gain insights into the structure

274 Thus, the BG505 Env protein warrants further investigation as an HIV vac

275 ch the cytoplasmic tail sequence of the MuLV Env protein was added to the HA cytoplasmic domain.

276 ved that the palmitoylation-deficient mutant Env protein was mostly soluble when extracted by ice-col

277 lated on serine residues, but the native BLV Env protein was not phosphorylated either in transfected

278 We found that the wild-type MuLV Env protein was resistant to ice-cold TX-100 treatment a

279 Env protein was undetectable in dead mutants, while RC a

280 t to the plasma membrane of selected deleted Env proteins was confirmed by confocal immunofluorescenc

281 among targeting peptides of library-selected Env proteins was greater than that found in parental FeL

282 Stable expression of these Gag and Env proteins was observed for more than 12 months.

283 he NXT/S N-linked glycosylation motif of the Env protein, we created 27 mutants lacking 1 to 5 of 14

284 In summary, using patient-derived Env proteins, we found that ENF failure was associated w

285 xplore whether Tier-2 nAbs can be induced by Env proteins, we immunized conventional mice with solubl

286 st, viruses pseudotyped with subtype A and C Env proteins were able to use the recently described alt

287 Mother and infant Env proteins were also similar in sensitivity to soluble

288 For these studies, libraries of Env proteins were cloned from infected subjects and scre

289 Both the wild-type and mutant Env proteins were found to be soluble when treated with

290 The nucleotide sequences of the Env proteins were then compared for pairs of neutralizat

291 simian immunodeficiency virus (SIV) Gag and Env proteins were used to vaccinate rhesus macaques with

292 ave created a RV containing a chimeric HIV-1 Env protein, which contains introduced cysteine residues

293 ociation of the murine leukemia virus (MuLV) Env protein with lipid rafts, we compared wild-type and

294 ergent in sequence, the two viruses share an Env protein with similarly curtailed VRA and VRB regions

295 protein, show that interaction of the viral Env protein with the virus entry receptor Hyal2 is not r

296 Screening on AH927 cells yielded Env proteins with a broader host range, with maximal tit

297 d the disulfide bond profiles of two soluble Env proteins with different designs that are being asses

298 Libraries of FeLV Env proteins with random amino acid substitutions in the

299 Here we show that JSRV and ENTV Env proteins with tyrosine or methionine mutations in th

300 The ability to isolate Env proteins with unique tropisms dependent on the cells